In breast cancer cell lines, hypoxia can modulate EGFR expression and downstream signalling in a DNA methylation‐specific and HIF‐dependent manner, altering the response to anti‐EGFR therapy.74 The gene discussed is EGFR; the disease is breast carcinoma.